Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study.
HDR brachytherapy
in vivo dosimetry
source tracking
Journal
Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
07
01
2021
received:
07
10
2020
accepted:
04
02
2021
pubmed:
4
3
2021
medline:
25
5
2021
entrez:
3
3
2021
Statut:
ppublish
Résumé
To report on the accuracy of an in vivo dosimetry (IVD)-based source tracking (ST) method for high dose rate (HDR) prostate brachytherapy (BT). The ST was performed on a needle-by-needle basis. A least square fit of the expected to the measured dose rate was performed using the active dwell positions in the given needle. Two fitting parameters were used to determine the position of each needle relative to the IVD detector: radial (away or toward the detector) and longitudinal (along the axis of the treatment needle). The accuracy of the ST was assessed in a phantom where the geometries of five HDR prostate BT treatments previously treated at our clinic were reproduced. For each of the five treatment geometries, one irradiation was performed with the detector placed in the middle of the implant. Furthermore, four additional irradiations were performed for one of the geometries where the detector was retracted caudally in four steps of 10-15 mm and up to 12 mm inferior of the most inferior active dwell position, which represented the prostate apex. The time resolved dose measurements were retrieved at a rate of 20 Hz using a detector based on an Al Source tracking could be applied in all needles across all nine irradiations. For irradiations with the detector located in the middle region of the implant (a total of 89 needles), the mean ± standard deviation (SD, k = 1) accuracy was -0.01 mm ± 0.38 mm and 0.30 mm ± 0.38 mm in the radial and longitudinal directions, respectively. Caudal retraction of the detector did not lead to reduced accuracy as long as the detector was located superior to the most inferior active dwell positions in all needles. However, reduced accuracy was observed for detector positions inferior to the most inferior active dwell positions which corresponded to detector positions in and inferior to the prostate apex region. Detector positions in the prostate apex and 12 mm inferior to the prostate resulted in mean ± SD (k = 1) ST accuracy of 0.7 mm ± 1 mm and 2.8 mm ± 1.6 mm, respectively, in radial direction, and -1.7 mm ± 1 mm and -2.1 mm ± 1.1 mm, respectively, in longitudinal direction. The largest deviations for the configurations with those detector positions were 2.6 and 5.4 mm, respectively, in the radial direction and -3.5 and -3.8 mm, respectively, in the longitudinal direction. This phantom study demonstrates that ST based on IVD during prostate BT is adequately accurate for clinical use. The ST yields submillimeter accuracy on needle positions as long as the IVD detector is positioned superior to at least one active dwell position in all needles. Locations of the detector inferior to the prostate apex result in decreased ST accuracy while detector locations in the apex region and above are advantageous for clinical applications.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2614-2623Subventions
Organisme : Aarhus University
Organisme : Novo Nordisk Fonden
ID : NNF19OC0058756
Organisme : The Danish National Research Center for Radiotherapy, Danish Cancer Society
ID : R191-A11526
Organisme : Danish Comprehensive Cancer Center
Informations de copyright
© 2021 American Association of Physicists in Medicine.
Références
Valentin J. International commission on radiation protection. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97. Ann ICRP. 2005;35:1-51.
Tanderup K, Beddar S, Andersen CE, Kertzscher G, Cygler JE. In vivo dosimetry in brachytherapy. Med Phys. 2013;40:070902.
IAEA. Lessons learned from accidental exposures in radiotherapy. IAEA Safety Report Series 17. Vienna: IAEA; 2000. https://www.iaea.org/publications/5818/lessons-learned-from-accidental-exposures-in-radiotherapy.
Poder J, Carrara M, Howie A, Cutajar D, Bucci J, Rosenfeld A. Derivation of in vivo source tracking error thresholds for TRUS-based HDR prostate brachytherapy through simulation of source positioning errors. Brachytherapy. 2019;18:711-719.
Fonseca GP, Johansen JG, Smith R, et al. In vivo dosimetry in brachytherapy: Requirements and future directions for research, development, and clinical practice. Phys Imaging Radiat Oncol. 2020;16:1-11.
Morton G, Chung HT, McGuffin M, et al. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy. Radiother Oncol. 2017;122:87-92.
Strouthos I, Tselis N, Chatzikonstantinou G, et al. High dose rate brachytherapy as monotherapy for localised prostate cancer. Radiother Oncol. 2018;126:270-277.
Smith RL, Haworth A, Panettieri V, Millar JL, Franich RD. A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking. Med Phys. 2016;43:2435.
Smith RL, Hanlon M, Panettieri V, et al. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging. Brachytherapy. 2018;17:111-121.
Fonseca G, Podesta M, Reniers B, Verhaegen F. MO-AB-BRA-03: Development of novel real time in vivo EPID treatment verification for brachytherapy. Med Phys. 2016;43:3691.
Bharat S, Kung C, Dehghan E, et al. Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate. Brachytherapy. 2014;13:640-650.
Masitho S, Kallis K, Strnad V, Fietkau R, Bert C. Error detection using an electromagnetic tracking system in multi-catheter breast interstitial brachytherapy. Phys Med Biol. 2019;64:205018.
Poulin E, Racine E, Binnekamp D, Beaulieu L. Fast, automatic, and accurate catheter reconstruction in HDR brachytherapy using an electromagnetic 3D tracking system. Med Phys. 2015;42:1227-1232.
Boutaleb S, Racine E, Fillion O, et al. Performance and suitability assessment of a real-time 3D electromagnetic needle tracking system for interstitial brachytherapy. J Contemp Brachytherapy. 2015;7:280-289.
Beaulieu L, Racine E, Han DY, Vigneault E, Hsu I-C, Cunha JAM. Real-time electromagnetic tracking-based treatment platform for high-dose-rate prostate brachytherapy: Clinical workflows and end-to-end validation. Brachytherapy. 2018;17:103-110.
Guiral P, Ribouton J, Jalade P, et al. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance. Med Phys. 2016;43:5240.
Rosales HML, Duguay-Drouin P, Archambault L, Beddar S, Beaulieu L. Optimization of a multipoint plastic scintillator dosimeter for high dose rate brachytherapy. Med Phys. 2019;46:2412-2421.
Andersen CE, Nielsen SK, Lindegaard JC, Tanderup K. Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy. Med Phys. 2009;36:5033.
Wang R, Ribouton J, Pittet P, Guiral P, Jalade P, Lu GN. Implementation of GaN based real-time source position monitoring in HDR brachytherapy. Radiat Meas. 2014;71:293-296.
Johansen JG, Kertzscher G, Jørgensen EB, et al. Dwell time verification in brachytherapy based on time resolved in vivo dosimetry. Phys Med. 2019;60:156-161.
Johansen JG, Rylander S, Buus S, et al. Time-resolved in vivo dosimetry for source tracking in brachytherapy. Brachytherapy. 2018;17:122-132.
Rosales HML, Archambault L, Beddar S, Beaulieu L. Dosimetric performance of a multipoint plastic scintillator dosimeter as a tool for real-time source tracking in high dose rate 192Ir brachytherapy. Med Phys. 2020;47:4477-4490.
Therriault-Proulx F, Beddar S, Beaulieu L. On the use of a single-fiber multipoint plastic scintillation detector for 192Ir high-dose-rate brachytherapy. Med Phys. 2013;40:062101.
Andersen CE, Nielsen SK, Greilich S, Helt-Hansen J, Lindegaard JC, Tanderup K. Characterization of a fiber-coupled luminescence dosimetry system for online in vivo dose verification during brachytherapy. Med Phys. 2009;36:708-718.
Buus S, Rylander S, Hokland S, et al. Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2016;15:426-434.
Perez-Calatayud J, Ballester F, Das RK, et al. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: Report of the AAPM and ESTRO: High-energy photon-emitting brachytherapy dosimetry. Med Phys. 2012;39:2904-2929.
Kertzscher G, Andersen CE, Edmund JM, Tanderup K. Stem signal suppression in fiber-coupled Al2O3:C dosimetry for 192Ir brachytherapy. Radiat Meas. 2011;46:2020-2024.
D’Amico AV, Davis A, Vargas SO, Renshaw AA, Jiroutek M, Richie JP. Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated? Int J Radiat Oncol Biol Phys. 1999;43:587-590.
Batič M, Burger J, Cindro V, et al. Verification of high dose rate 192Ir source position during brachytherapy treatment. Nucl Instrum Methods Phys Res, Sect A. 2010;617:206-208.
Rosales HML, Johansen JG, Kertzscher G, Tanderup K, Beaulieu L, Beddar S. 3D source tracking and error detection in HDR using two independent scintillator dosimetry systems. Med Phys. https://doi.org/10.1002/mp.14607.
Kertzscher G, Andersen CE, Tanderup K. Adaptive error detection for HDR/PDR brachytherapy: Guidance for decision making during real-time in vivo point dosimetry. Med Phys. 2014;41:052102.
Wagner D, Hermann M, Hille A. In vivo dosimetry with alanine/electron spin resonance dosimetry to evaluate the urethra dose during high-dose-rate brachytherapy. Brachytherapy. 2017;16:815-821.
Kertzscher G, Andersen CE, Siebert F-A, Nielsen SK, Lindegaard JC, Tanderup K. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion. Radiother Oncol. 2011;100:456-462.
Buus S, Lizondo M, Hokland S, et al. Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI. Brachytherapy. 2018;17:50-58.
Andersen CE, Edmund JM, Damkjaer SMS, Greilich S. Temperature coefficients for in vivo RL and OSL dosimetry using. Radiat Measur. 2008;43:948-953.
Andersen CE, Damkjaer SMS, Kertzscher G, Greilich S, Aznar MC. Fiber-coupled radioluminescence dosimetry with saturated Al2O3:C crystals: Characterization in 6 and 18 MV photon beams. Radiat Meas. 2011;46:1090-1098.